World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
83
Citations
25427
World Ranking
987
National Ranking
450

Medicine

D-Index
85
Citations
26305
World Ranking
14620
National Ranking
7395

John R. Graybill publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where John R. Graybill sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 287 publications — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

John R. Graybill D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where John R. Graybill sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 83 D-Index — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

John R. Graybill is affiliated with The University of Texas Health Science Center at San Antonio in the United States. Their research primarily focuses on the field of Medicine, with three publications attributed to this area.

The scientist's subfields of study include Epidemiology, with two publications, and Infectious Diseases, with one publication. These specialties provide a foundation for their work in clinical and public health contexts.

The main topics addressed in their research encompass fungal infections and studies, antifungal resistance and susceptibility, and nail diseases and treatments. Each of these topics is represented by two publications, highlighting a focused engagement with conditions involving fungal pathogens and associated therapeutic challenges.

  • Fungal Infections and Studies
  • Antifungal Resistance and Susceptibility
  • Nail Diseases and Treatments

Collaboratively, John R. Graybill has frequently co-authored with Gregory M. Anstead, with this partnership documented through one joint publication.

Best Publications

  • Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.

    John R. Perfect;William E. Dismukes;Francoise Dromer;David L. Goldman

  • Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group.

    Thomas F. Patterson;William R. Kirkpatrick;Mary White;John W. Hiemenz

  • Treatment of Cryptococcal Meningitis Associated with the Acquired Immunodeficiency Syndrome

    van der Horst Cm;Saag Ms;Cloud Ga;Hamill Rj

  • Diagnosis and Management of Increased Intracranial Pressure in Patients with AIDS and Cryptococcal Meningitis

    J R Graybill;J Sobel;M Saag;C van Der Horst

  • NIAID mycoses study group multicenter trial of oral itraconazole therapy for invasive aspergillosis

    David W. Denning;David W. Denning;Jeanette Y. Lee;Jeanette Y. Lee;John S. Hostetler;John S. Hostetler;Peter Pappas;Peter Pappas

  • Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria

    Brahm H. Segal;Raoul Herbrecht;David A. Stevens;David A. Stevens;Luis Ostrosky-Zeichner

  • In Vitro Activities of Posaconazole, Itraconazole, Voriconazole, Amphotericin B, and Fluconazole against 37 Clinical Isolates of Zygomycetes

    Qiu N. Sun;Annette W. Fothergill;Dora I. McCarthy;Michael G. Rinaldi;Michael G. Rinaldi

  • A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group.

    W G Powderly;M S Saag;M S Saag;G A Cloud;G A Cloud;P Robinson;P Robinson

  • Posaconazole as Salvage Treatment for Invasive Fusariosis in Patients with Underlying Hematologic Malignancy and Other Conditions

    Issam I. Raad;Ray Y. Hachem;Raoul Herbrecht;John R. Graybill

  • In Vitro Activity of Caspofungin against Candida albicans Biofilms

    Stefano P. Bachmann;Kacy VandeWalle;Gordon Ramage;Thomas F. Patterson

  • Pharmacokinetics of itraconazole following oral administration to normal volunteers.

    T C Hardin;J R Graybill;R Fetchick;R Woestenborghs

  • Activity of posaconazole in the treatment of central nervous system fungal infections

    Punnee Pitisuttithum;Ricardo Negroni;John R. Graybill;Beatriz Bustamante

  • A Comparison of Itraconazole Versus Fluconazole as Maintenance Therapy for AIDS-Associated Cryptococcal Meningitis

    Michael S. Saag;Gretchen A. Cloud;J. Richard Graybill;Jack D. Sobel

  • Treatment of murine cryptococcosis with liposome-associated amphotericin B.

    John R. Graybill;Philip C. Craven;Robert L. Taylor;Dwight M. Williams

  • Safety of long-term oral posaconazole use in the treatment of refractory invasive fungal infections.

    Issam I. Raad;John R. Graybill;Ana Beatriz Bustamante;Oliver A. Cornely

  • Voriconazole in the treatment of fungal eye infections: a review of current literature

    Unknown

  • Disruption of a nonribosomal peptide synthetase in Aspergillus fumigatus eliminates gliotoxin production.

    Robert A. Cramer;Michael P. Gamcsik;Rhea M. Brooking;Laura K. Najvar

  • High-Dose Ketoconazole Therapy and Adrenal and Testicular Function in Humans

    A. Pont;J.R. Graybill;P.C. Craven;J.N. Galgiani

  • In vivo activity of posaconazole against Mucor spp. in an immunosuppressed-mouse model.

    Qiu N. Sun;Laura K. Najvar;Rosie Bocanegra;David Loebenberg

  • Fluconazole Therapy for Coccidioidal Meningitis

    John N. Galgiani;Antonino Catanzaro;Gretchen A. Cloud;Jean Higgs

  • Itraconazole treatment of phaeohyphomycosis.

    Patricia Kay Sharkey;John R. Graybill;Michael G. Rinaldi;David A. Stevens

  • Amphotericin B Lipid Complex Compared with Amphotericin B in the Treatment of Cryptococcal Meningitis in Patients with AIDS

    Patricia K. Sharkey;John R. Graybill;Edward S. Johnson;Stephen G. Hausrath

Frequent Co-Authors

Laura K. Najvar
Laura K. Najvar The University of Texas Health Science Center at San Antonio
Michael G. Rinaldi
Michael G. Rinaldi The University of Texas Health Science Center at San Antonio
David A. Stevens
David A. Stevens Stanford University
Thomas F. Patterson
Thomas F. Patterson The University of Texas Health Science Center at San Antonio
Nathan P. Wiederhold
Nathan P. Wiederhold The University of Texas Health Science Center at San Antonio
William E. Dismukes
William E. Dismukes University of Alabama at Birmingham
John N. Galgiani
John N. Galgiani University of Arizona
John R. Perfect
John R. Perfect Duke University
Annette W. Fothergill
Annette W. Fothergill The University of Texas Health Science Center at San Antonio
David W. Denning
David W. Denning University of Manchester

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring microbiology can open doors to diverse career options, many of which offer flexible online degree opportunities. For those interested in healthcare, pursuing medical degrees online allows students to gain essential skills while balancing other commitments. These programs often serve as a strong foundation for careers in biomedical research or clinical microbiology.

Public health is another complementary field, with several accessible programs designed for quick entry. Students seeking to advance their knowledge efficiently should consider the fastest and easiest online MPH programs. These degrees emphasize population health and epidemiology, which are closely linked to microbiological studies.

For those interested in applied healthcare roles supporting children and families, becoming a child life specialist is a meaningful career path. This role combines science understanding with emotional support, making it a unique option alongside microbiology-related fields.

Importantly, online education offers inclusive opportunities for many learners. There are online colleges that accept felons, opening pathways for individuals seeking second chances through education. These programs can lead to careers in various scientific and healthcare domains, highlighting the accessibility of microbiology and related degrees.

Best Scientists Citing John R. Graybill

Trending Scientists

Recently Published Articles